The fifth edition of the World Health Organization Classification of Tumors of Soft Tissue and
Bone was published in early 2020. The revisions reflect a consensus among an …

The fifth edition of the World Health Organization (WHO) classification of soft tissue and
bone tumours was published in May 2020. This 'Blue Book', which is also available digitally …

Background Epithelioid hemangioendothelioma is a malignant, often indolent vascular
tumor which occurs at various anatomic sites. Based on a reciprocal translocation t (1; …

Integration of morphological, immunohistochemical, and molecular methods is often
necessary for the precise diagnosis and optimal clinical management of sarcomas. We have …

The fourth edition of the World Health Organization (WHO) Classification of Tumours of Soft
Tissue and Bone 1 was published in 2013, and represents an updated consensus text …

Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma is a distinctive vascular
neoplasm of intermediate biological potential with a predilection for young adults and …

The transcription factor FOS has long been implicated in the pathogenesis of bone tumours,
following the discovery that the viral homologue, v-fos, caused osteosarcoma in laboratory …

Epithelioid hemangioma (EH) is a unique benign vasoformative tumor composed of
epithelioid endothelial cells. Although a small subset of EHs with atypical features harbor …

The fifth (5th) edition of the World Health Organization (WHO) Classification of Head and
Neck Tumors introduces a new chapter dedicated to soft tissue neoplasms commonly …

Sarcomas include diverse mesenchymal neoplasms with widely varied prognosis, clinical
behavior, and treatment. Owing to their rarity and histologic overlap, accurate diagnosis of …